Detalles de la búsqueda
1.
Identification of a ß-arrestin-biased negative allosteric modulator for the ß2-adrenergic receptor.
Proc Natl Acad Sci U S A;
120(31): e2302668120, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37490535
2.
Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival.
Cancer Immunol Immunother;
72(4): 945-954, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36197494
3.
Correction to: Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival.
Cancer Immunol Immunother;
72(4): 955, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36538061
4.
Prediction of consensus binding mode geometries for related chemical series of positive allosteric modulators of adenosine and muscarinic acetylcholine receptors.
J Comput Chem;
38(15): 1209-1228, 2017 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28130813
Resultados
1 -
4
de 4
1
Próxima >
>>